REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 98 filers reported holding REPROS THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | -100.0% | 343 | -77.2% | 0.00% | – |
| Q3 2016 | $3,000 | -25.0% | 1,506 | -54.6% | 0.00% | -100.0% |
| Q4 2015 | $4,000 | +100.0% | 3,315 | +1136.9% | 0.00% | – |
| Q2 2015 | $2,000 | -84.6% | 268 | -82.8% | 0.00% | -100.0% |
| Q1 2015 | $13,000 | +225.0% | 1,561 | +323.0% | 0.00% | – |
| Q4 2014 | $4,000 | -20.0% | 369 | +19.8% | 0.00% | -100.0% |
| Q1 2014 | $5,000 | -94.9% | 308 | -91.6% | 0.00% | -90.9% |
| Q3 2013 | $99,000 | +371.4% | 3,677 | +220.0% | 0.01% | +450.0% |
| Q2 2013 | $21,000 | – | 1,149 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
| Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
| GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
| Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
| Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
| Renaissance Technologies | 716,413 | $946,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
| Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |